PMI's IQOS Revenue Surpasses Marlboro, Aiming for 100B sales

Oct.11.2024
PMI's IQOS Revenue Surpasses Marlboro, Aiming for 100B sales
According to El Economista on October 9, Philip Morris International's IQOS device surpasses Marlboro in revenue, reaching $10 billion.

According to El Economista on October 9th, 38% of Philip Morris International's (PMI) global net income comes from non-cigarette alternative products. Revenue from their heated tobacco device "IQOS" has surpassed that of their most important cigarette brand Marlboro for the first time, with IQOS projected to exceed $10 billion in global sales by 2023.


It is reported that PMI's cigarette alternative products have now entered over 90 markets worldwide, with a total investment of $14 billion and a team of 1,500 people working on innovation.


The company's CEO, Jacek Olczak, stated during a media briefing in Neuchâtel, Switzerland, that...


The figures we have achieved are remarkable. Despite realizing that the market is developing faster than expected, there is still a long way to go.


Eujia further emphasized that it took IQOS 10 years to achieve sales of $10 billion, while Meta took 9 years, Amazon took 12 years, and Tesla took 14 years.


Philip Morris International (PMI) believes that there are 1.1 billion smokers worldwide and that the current measures being implemented are not effective enough. The IQOS device was initially launched in Milan, Italy, and Nagoya, Japan, and now has 30.8 million users. Oscar Jager stated, "In some countries, such as Japan, alternatives have already surpassed traditional cigarettes." He further emphasized that the company will continue to invest in new innovations to accelerate the transformation and aims to achieve 66% of revenue from alternatives by 2030.


However, the spokesperson acknowledged that due to insufficient information, many countries are skeptical of alternative products.


Some activists claim that these products are just as harmful as cigarettes, but we have proven that this is not true. People need to make informed decisions, as there is no scientific research indicating that these products are exactly the same as cigarettes.


Ouyaje criticized some government's strict regulation.


They refuse to listen to our advice because we are a tobacco company, but all of this is based on scientific data - nicotine does not cause cancer. This situation is similar to the COVID-19 vaccine, where some people are unwilling to get vaccinated despite scientific evidence.


He also stated that the World Health Organization "even refused to respond to our information".


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI says it submitted evidence to FDA panel backing ZYN bid for modified-risk status
PMI says it submitted evidence to FDA panel backing ZYN bid for modified-risk status
Philip Morris International said it presented scientific evidence to the U.S. Food and Drug Administration’s Tobacco Products Scientific Advisory Committee to support its ZYN nicotine pouches seeking a modified risk tobacco product designation, which would allow the company to communicate to adult smokers that switching completely to ZYN could reduce the risk of multiple smoking-related diseases.
Jan.26 by 2FIRSTS.ai
U.S. FDA Posts Final ZYN MRTP Materials, Sets March 4 Deadline for Public Comments
U.S. FDA Posts Final ZYN MRTP Materials, Sets March 4 Deadline for Public Comments
U.S. FDA has released the final batch of materials for ZYN MRTP applications and set March 4 (11:59 p.m. ET) as the deadline for public comments to be considered in the agency’s review.
Feb.03 by 2FIRSTS.ai
PMI reshuffles South Africa leadership, appoints first female general manager
PMI reshuffles South Africa leadership, appoints first female general manager
Philip Morris International (PMI) said it has appointed Buena Barnes as general manager of its South Africa business, marking the first time a woman has held the role in the country. Barnes previously oversaw finance for Sub-Saharan Africa and has worked at GlaxoSmithKline South Africa and British American Tobacco South Africa.
Jan.19 by 2FIRSTS.ai
Singapore sentencing: 17,000+ vape pods seized; man convicted of multiple offences
Singapore sentencing: 17,000+ vape pods seized; man convicted of multiple offences
A 28-year-old man in Singapore was sentenced on Jan 22 after admitting to six offences spanning 2021 to 2024, including possessing vapes and vape pods for sale.
Jan.23 by 2FIRSTS.ai
Thai police arrest 23-year-old woman linked to major vape-smuggling network in the South
Thai police arrest 23-year-old woman linked to major vape-smuggling network in the South
Thai police said officers expanded an investigation into a major e-cigarette smuggling network in the South and arrested a 23-year-old woman at Hat Yai Junction railway station on Jan. 6, 2026.
Jan.08 by 2FIRSTS.ai
BAT CEO: to ramp up ‘next-generation’ tobacco capacity in Italy, plans €500 mln investment in Trieste plant by 2027
BAT CEO: to ramp up ‘next-generation’ tobacco capacity in Italy, plans €500 mln investment in Trieste plant by 2027
British American Tobacco (BAT) CEO Tadeu Marroco said the group will continue to invest in equipment and technology in Italy and expand capacity for next-generation tobacco products such as e-cigarettes and heated tobacco. BAT’s Trieste innovation hub is slated to receive a total investment of 500 million euros by 2027 and add 16 new production lines.
Feb.03 by 2FIRSTS.ai